Abstract:Setting The poor patient adherence in tuberculosis (TB) treatment is considered to be one of the most serious challenges which reflect the decrease of treatment success and emerging of the Multidrug Resistance-TB (MDR-TB). To our knowledge, the data about patients' adherence to anti-TB treatment in our country are missing. Objective This study was aimed to investigate the anti-TB treatment adherence rate and to identify factors related to eventual nonadherence among Kosovo TB patients. Design This study was co… Show more
“…However, it is higher than studies done in North Gondar Zone- Northwest Ethiopia (10% and 13.6%) [ 16 ], Khartoum state, Sudan (14%) [ 18 ], State of Parana (8.5% %) [ 19 ], Kosovo (14.5%) [ 6 ], and Thailand (15.6%) [ 8 ]. This difference might be due to differences in socio-demographic characteristic, sample size, study designs, settings and time difference.…”
Section: Discussionmentioning
confidence: 82%
“…The main risk factors for developing active TB case are human immunodeficiency syndrome (HIV) infection, low socioeconomic status/poverty, alcoholism, homelessness, crowded living condition, diseases that weaken the immune system, migration from country with high number of cases, and health-care workers [ 4 ]. Tuberculosis non-adherence is the major challenge in TB treatment which leads multidrug as well as extended drug-resistant TB [ 5 , 6 ]. Combating non-adherence is the key and cornerstone of anti TB treatment.…”
ObjectiveThe aim of this study was to assess the prevalence of non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers.ResultA total of 314 participants were included with the response rate of 97.5%. The mean age of participants was 35.94 (SD ± 13.83) years. The overall rate of non-adherence to anti-TB treatment was 21.2% (95% CI 17.2, 26.1). Continuation phase of treatment (AOR = 2.27, 95% CI (1.54, 5.94)), presence of more than one co-morbidity (AOR = 6.22; 95% CI (2.21, 17.48)), poor knowledge about TB and anti-TB therapy (AOR = 4.11; 95% CI 1.57, 10.75), poor patient-provider relationship (AOR = 4.60, 95% CI 1.63, 12.97), and alcohol intake (AOR = 5.03; 95% CI 1.54, 16.40) were significantly associated with non-adherence. Forgetting 40 (23.1%), Being busy with other work 35 (20.2%), and being out of home/town 24 (13.9%) were the major reasons of participants for interruption of taking anti-TB medications.Electronic supplementary materialThe online version of this article (10.1186/s13104-018-3789-4) contains supplementary material, which is available to authorized users.
“…However, it is higher than studies done in North Gondar Zone- Northwest Ethiopia (10% and 13.6%) [ 16 ], Khartoum state, Sudan (14%) [ 18 ], State of Parana (8.5% %) [ 19 ], Kosovo (14.5%) [ 6 ], and Thailand (15.6%) [ 8 ]. This difference might be due to differences in socio-demographic characteristic, sample size, study designs, settings and time difference.…”
Section: Discussionmentioning
confidence: 82%
“…The main risk factors for developing active TB case are human immunodeficiency syndrome (HIV) infection, low socioeconomic status/poverty, alcoholism, homelessness, crowded living condition, diseases that weaken the immune system, migration from country with high number of cases, and health-care workers [ 4 ]. Tuberculosis non-adherence is the major challenge in TB treatment which leads multidrug as well as extended drug-resistant TB [ 5 , 6 ]. Combating non-adherence is the key and cornerstone of anti TB treatment.…”
ObjectiveThe aim of this study was to assess the prevalence of non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers.ResultA total of 314 participants were included with the response rate of 97.5%. The mean age of participants was 35.94 (SD ± 13.83) years. The overall rate of non-adherence to anti-TB treatment was 21.2% (95% CI 17.2, 26.1). Continuation phase of treatment (AOR = 2.27, 95% CI (1.54, 5.94)), presence of more than one co-morbidity (AOR = 6.22; 95% CI (2.21, 17.48)), poor knowledge about TB and anti-TB therapy (AOR = 4.11; 95% CI 1.57, 10.75), poor patient-provider relationship (AOR = 4.60, 95% CI 1.63, 12.97), and alcohol intake (AOR = 5.03; 95% CI 1.54, 16.40) were significantly associated with non-adherence. Forgetting 40 (23.1%), Being busy with other work 35 (20.2%), and being out of home/town 24 (13.9%) were the major reasons of participants for interruption of taking anti-TB medications.Electronic supplementary materialThe online version of this article (10.1186/s13104-018-3789-4) contains supplementary material, which is available to authorized users.
“…shows that TB remains a threatening socio-epidemiological disease in our country; thus, the DOTS strategy needs to be strengthened. 16 Urban registered patients were more common than rural patients (66.67 vs 33.33%), and the greatest difference was observed in the inpatient and outpatient groups (68.60% vs 31.40% and 65.34% vs 34.66%, respectively).…”
Background
Tuberculosis (TB) remains a significant worldwide social and life‐threatening epidemiological problem. Because this disease requires multiple drug treatment and prolonged therapy for several months, followed by a high probability of adverse effects (AEs), we assessed AE monitoring for anti‐TB drugs in the Health Care System of Kosova.
Methods
This survey was a cross‐sectional analysis performed at the primary, secondary and tertiary health care levels in Kosova. We included 930 registered tuberculosis patients within three levels of this health system in our study. Furthermore, we interviewed 62 physicians and 71 nurses at TB health facilities. Data were collected from official TB registers and personal contact with patients for 12 months.
Results
The representative age group was 19 to 29 years (30.49%), followed by a group of patients aged >60 years (23.23%). Among 930 patients treated with TB drugs, the total incidence of adverse AEs was 29.03%. Female TB patients had a higher rate of AEs than did male patients (33.56% vs 28.84%, respectively). The highest incidence of registered AEs was recorded in the gastrointestinal system (270, 80.83%), followed by the central nervous system (CNS, 7.50%) and was lower in other organ systems. The reporting of anti‐TB drug effects by medical staff (TB medical doctor and TB medical nurse) at different levels of TB medical settings occurred among 62.90% of medical doctors and 81.69% of nurses. Only 53.23% of medical doctors and 46.48% of nurses completed pharmacovigilance training.
Conclusion
The pharmacovigilance approach in Health System of Kosova is not comprehensible and not systematic. The relatively low incidence of AEs among TB patients is due under reporting of these by medical staff. The knowledge, attitudes, and adherence of medical staff reveal low awareness for pharmacovigilance activities, and this concern should be addressed to reinforce this important issue for the safe treatment of TB patients.
“…Актуальність теми. В етіологічному профілі інфекційних захворювань людей за своєю здатністю причиняти загибель організму лідирують мікобактерії туберкульозу (Eskild et al, 2019;Tiberi et al, 2018;Krasniqi et al, 2017;Moore, 2016).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.